DEADLY BIRTH CONTROL: The Black is Back Coalition joins the fight to expose the racist, eugenicist agendas of those posing as reproductive health advocates to target Black women the world over by deceptively marketing the drug Depo Provera to our community as a safe and effective form of birth control; however, the reality is that it is the deadliest form of birth control that not only increases sterilization and breast cancer among users, but that also significantly increases a personâs chances of acquiring and transmitting HIV/AIDS. The well researched report âDepo-Provera: Deadly Violence Against Women,âpublished by the Rebecca Project for Human Rights, documents the agendas of Pfizer, The Bill and Melinda Gates Foundation, Planned Parenthood, the US Agency for International Development(USAID), the UN, the World Health Organization, the Center for Disease Control, Columbia and Johns Hopkins Universities and a host of many other population control advocates and eugenicists who deceitfully mask the dangers of Depo-Provera (more commonly known as the depo-shot), a controversial and potentially lethal birth control drug, in order to push their eugenicist agenda, via its widespread usage into the Black community. African women and other women of color are targeted throughout the world and are often coerced into taking the depo-shot, in which the side effects include difficulty getting pregnant/sterilization, increased risk of breast cancer, and increased risks of contracting and transmitting HIV/AIDs. Modern day eugenicists deliberately hide these dangerous side effects from the Black community, whose women have been repeatedly used worldwide in Depo-Provera experimentation, without informed consent. One such experiment, which was the largest experiment to date of its kind, lasted from 1967 to 1978 and involved 14,000 low income women in Atlanta Georgia at the Grady clinic (http://www.cwpe.org/node/185). They were never informed that they were being used for experimentation and they were never informed of the drugâ s grave side effects. Many women developed cancer and many died Another such experiment lasted from 1994 to 2006 and involved over 9000 impoverished women in Ghana. Again, informed consent was never obtained from these women, who were merely told that they were receiving routine healthcare. This experiment was conducted by Dr. James Phillips, who is presently a member of the faculty of the Mailman School of Public Health at Columbia University. Today, Depo-Provera is promoted by such population control advocates throughout our communities as a safe and effective contraceptive. As evidenced, Depo-Provera has a long and controversial history. From the 1960s to the 80s, the FDA withheld its approval of Depo three times because of consistent links to cancer in test animals. In 1992 it finally received FDA approval over the objections of many womenâs rights health organizations (http://www.cwpe.org/node/185). In 2004 the FDA identified Depo-Provera as causing serious side effects and issued Black- Box warnings, which are the most stringent warnings mandated by the FCC to notify the public of the significant risk of serious and potentially life threating side effects posed by a drug. The FDA mandated that patients be notified that: 1). Women may lose significant bone mineral density that is not fully reversible and, therefore, (2) Depo Provera should not be used as a long-term birth control method for more than two years. Other warnings include: (3) blood clots in arms, legs, lungs and eyes, (4) stroke, (5) bleeding irregularities, (6)weight gain, (7) ectopic pregnancy, and (8) delayed return to fertility and lack of return to fertility. (9) In addition, scientific research in 2012 reported that women using Depo Provera have double the risk of developing breast cancer. (10). Depo- Provera also has an unintended consequence of significantly increasing a womanâs susceptibility to HIV/AIDS and all other sexually transmitted diseases due to the fact that the high dose of progesterone in Depo-Provera induces thinning of the vaginal walls. (page 1) In a 2011 study of seven African countries involving over 3,000 participants, researchers, led by Renee Heffron at the University of Washington in Seattle, found that women who used Depo-Provera were twice as likely to acquire, as well as to transmit, HIV/AIDS as those who did not; thus, strongly demonstrating a correlation between aggressive promotion of Depo and the HIV/AIDs epidemic ravishing the African continent. (Yet despite these disturbing findings, USAID sends more units of Depo Provera to Africa than any other country in the world). In fact, South Africa is considered the country with the highest rate of AIDS in the world, with the groups most at risk being women aged 25 and 29 and men aged 30 -34. Not coincidentally, South Africa is also one of the countries with the worldâs highest Depo usage. Also, ln 2009 the CDC reported that African Americans were 44% of all new HIV infections. Yet, African American women make up 84% of Depo-Provera users. On the other hand, UN data shows that the administration of Depo-Provera to European populations is negligible and averages between .7% and 2% worldwide. Meanwhile the birth rate for African American women has dropped by 30%, compared to only 5% for White American women. In 2011 the CDC reported that Black women in the US had 583,079 births, while White women had 2,150,926 births. In spite of the serious and deadly implications of using this type of birth control, and in spite of the FDA mandated black box warnings, population control advocates continue to illegally promote Depo without black box warnings and without signed informed consent forms informing users of its gravity. In fact, the WHO and the CDC went as far as issuing a statement stating that not only did Depo-Provera not increase a womanâs chance of contracting AIDS, but that it was also perfectly safe for use with women who had the disease. On its website, Planned Parenthood promotes the drug as safe, effective and convenient. It lists the side effects as being: irregular menstrual cycles, weight gain, hair loss, change in appetite, depression, and sore breasts. The International Criminal Court defines genocide in part as committing acts with the intent to destroy, in whole or in part, a national, ethnical, racial or religious group, such as killing members of the group, causing bodily or mental harm to members of the group, and imposing measures to prevent births within the group. The Black is Back Coalition commends the Rebecca Project for its excellent and well documented research and supports its conclusion that the administering of the lethal contraceptive Depo-Provera to millions of women of color and impoverished women, while fraudulently concealing the dangers of its use is a policy of genocide. Therefore, we join the Rebecca Project in its call for the following actions: ⢠The DOJ bring Pfizer up on criminal charges of fraud. ⢠That the President issue a moratorium on the use of Depo-Provera to protect all women of color until informed and enforceable consent procedures are in place. ⢠That all Medicaid, state insurance programs, and USAID payments to Pfizer and USAID contractors be immediately stopped. ⢠That the US government hold Congressional Hearings where victims of non-consensual experimentation can testify to bring public attention to the matter. ⢠That we work to create a global coalition of advocates to monitor unethical medical experimentation in Africa. (Forthcoming will be a more detailed analysis and proposal pertaining to the rampant, abusive, and unethical medical experimentation underway on the African Continent.) Resources: http://rebeccaprojectjustice.org/images/stories/depo-provera-deadly-reproductive-violence-rebecca-project-for-human-rights-2013.pdf http://labeling.pfizer.com/ShowLabeling.aspx?id=522 http://www.cwpe.org/node/185 http://www.avert.org/aidssouthafrica.htm http://www.cdc.gov/hiv/pdf/risk_HIV_AAA.pdf http://www.plannedparenthood.org/health-topics/birth-control/birth-control-shot-depo-provera-4242.htm http://www.global-sisterhood-network.org/content/view/2642/59/